Beneficial Effects of Vitamin D Combined With Oral Iron Supplementation in Patients With Chronic Heart Failure and Iron Deficiency

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 258 participants.

Also called NCT05702970

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 258 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05702970
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT05702970. Randomized; single masking; primary purpose treatment. Start 2024-01-15 (anticipated); primary completion 2025-04-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Beneficial Effects of Vitamin D Combined With Oral Iron Supplementation in Patients With Chronic Heart Failure and Iron Deficiency
Acronym
VICTORID-HF
Condition
Heart Failure
Condition
Iron-deficiency
Condition
Heart Failure, Systolic
Condition
Heart Failure NYHA Class II
Condition
Heart Failure NYHA Class III
Condition
Vitamin D Deficiency
Intervention (Drug)
Sucrosomial iron
Intervention (Drug)
Vitamin D
Intervention (Drug)
Ferric Carboxymaltose 50 MG/ML
Lead sponsor
University of Padova (class: other)

Record details

Record id
cardio:ct-nct05702970
Content hash
5ddbd501f0cd63890d66aaad24ce6f17446be86ca03595c76e663343237ea8cb